Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
16
Number of overlapping holdings
25.8%
% of XLV's 62 holdings also in FTXH
32.0%
% of FTXH's 51 holdings also in XLV
Overlap by Weight
Sector Drift (XLV minus FTXH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in FTXH |
Overlap | |
|---|---|---|---|---|
 |
JOHNSON & JOHNSON | 6.8% | 6.9% | 6.8% |
|
ABBVIE INC | 5.9% | 6.9% | 5.9% |
|
MERCK & CO. INC. | 5.0% | 6.7% | 5.0% |
|
ELI LILLY & CO | 12.0% | 3.2% | 3.2% |
|
AMGEN INC | 2.8% | 3.1% | 2.8% |
Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to FTXH
|
UNITEDHEALTH GROUP INC | 9.3% |
|
ELI LILLY & CO | 8.8% |
|
THERMO FISHER SCIENTIFIC INC | 3.9% |
|
ABBOTT LABORATORIES | 3.8% |
|
INTUITIVE SURGICAL INC | 3.7% |
|
DANAHER CORP | 2.9% |
|
BOSTON SCIENTIFIC CORP | 2.6% |
|
STRYKER CORP | 2.5% |
 |
MEDTRONIC PLC | 2.0% |
|
VERTEX PHARMACEUTICALS INC | 1.8% |
XLV Underweight Relative to FTXH
|
BRISTOL-MYERS SQUIBB CO | -6.5% |
|
PFIZER INC | -4.0% |
|
VIATRIS, INC. | -3.8% |
|
UNITED THERAPEUTICS CORP | -3.7% |
|
CARDINAL HEALTH INC | -3.5% |
|
JAZZ PHARMACEUTICALS PLC | -3.5% |
|
ORGANON & CO. | -2.5% |
|
BIOGEN IDEC INC | -2.4% |
|
GILEAD SCIENCES INC | -2.3% |
|
CHARLES RIVER LABORATORIES | -2.3% |